A Study of Nivolumab in Participants With Metastatic or Unresectable Bladder Cancer

Clinical trial NCT02387996 · COMPLETED

Trial details

NCT number: NCT02387996
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Various Advanced Cancer

Start date: 2015-03-09
Primary completion: 2016-04-15
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.